LobbyingRevelle Aesthetics lobbying by quarter
Revelle Aesthetics's latest lobbying report covers Q2 2026, at $300K. The four quarters Q4 2025–Q3 2026 total $900K. Its first report covers Q2 2025; the issues it reports most are Medical/Disease Research/Clinical Labs.
Revelle Aesthetics
- Latest quarter
- No record
- Q3 2026 · 0 reports
- Last 12 months
- $900K
- Last 4 quarters
- vs last quarter
- −100.0%
- Q3 2026 against the quarter before
- First report
- Q2 2025
- The first quarter a report named it
Lobbying by quarter
| Quarter | Amount | Reports |
|---|---|---|
| Q2 2025 | $200K | 1 |
| Q3 2025 | $300K | 1 |
| Q4 2025 | $300K | 1 |
| Q1 2026 | $300K | 1 |
| Q2 2026 | $300K | 1 |
| Q3 2026 | $0 | 0 |
By issue
- Medical research and clinical labs$1.4M · 5 reports
An issue's amount splits each report's amount equally over the issues the report lists.
Who was lobbied
- Health & Human Services, Dept of (HHS)3 reports
- White House Office1 reports
Firms it paid
| Firm | ||
|---|---|---|
| Ballard Partners | $1.4M | 5 quarters |
Former officials lobbying for it
No lobbyist with a covered position.
Lobbying reports
| Filed by | ||
|---|---|---|
| 07/16for Q2 | Ballard Partners | $300K |
| 04/16for Q1 | Ballard Partners | $300K |
| 01/15for Q4 2025 | Ballard Partners | $300K |
| 25/10/17for Q3 2025 | Ballard Partners | $300K |
| 25/07/17for Q2 2025 | Ballard Partners | $200K |
| 25/06/03for Q2 2025 | Ballard Partners | Under $5,000 |